Skip to main content
      RT @Janetbirdope: #PJP prophylaxis debate at #lupus hub if on #prednisone + immune suppression. #SLE has ⤴️septra si

      Janet Pope Janetbirdope

      3 years 2 months ago
      #PJP prophylaxis debate at #lupus hub if on #prednisone + immune suppression. #SLE has ⤴️septra side effects. Don’t know right answer. NNT v NNH is unknown. I don’t use it in #SLE. @RheumNow #ACR21 8M212
      RT @doctorRBC: Post-hoc analysis of Deucravacitinib (TYK2i) for tx of PsA showed similar efficacy in pts with and withou

      Robert B Chao, MD doctorRBC

      3 years 2 months ago
      Post-hoc analysis of Deucravacitinib (TYK2i) for tx of PsA showed similar efficacy in pts with and without background csDMARD use. ⭐️>60% w/ background csDMARD use, majority of which was MTX ⭐️no difference in AE #ACR21 Abs#1352 @RheumNow https://t.co/nIJT7rNkJP https://t.co/bq0x1Ywguo
      RT @DrMiniDey: Does #baricitinib affect #fatigue in RA patients?

      👉🏼Results from RA-BEAM and RA-BEACON
      👉🏼4mg

      Mrinalini Dey DrMiniDey

      3 years 2 months ago
      Does #baricitinib affect #fatigue in RA patients? 👉🏼Results from RA-BEAM and RA-BEACON 👉🏼4mg baricitinib significantly reduced fatigue, starting week 16, compared to placebo 👉🏼Effect independent of disease activity in active RA Abs#1235 #ACR21 @RheumNow https://t.co/0SKhUKJHd7 https://t.co/R76wc56u6I
      RT @AkhilSoodMD: Go @utmbhealth!
      Final Round Knowledge Bowl #ACR21 @RheumNow
      @UTMBInternalMed #DanielGonzalez #AparnaDa

      Akhil Sood MD AkhilSoodMD

      3 years 2 months ago
      Go @utmbhealth! Final Round Knowledge Bowl #ACR21 @RheumNow @UTMBInternalMed #DanielGonzalez #AparnaDas https://t.co/nQRn3s7J21
      RT @DrPetryna: Abst 1550 #acr21 @RheumNow @bryan_neel rheum pts after covid 19 vaccine: 18.9% reported SEs after the 1s

      Olga Petryna DrPetryna

      3 years 2 months ago
      Abst 1550 #acr21 @RheumNow @bryan_neel rheum pts after covid 19 vaccine: 18.9% reported SEs after the 1st dose,33.1% after 2nd dose. most frequent SEs fever, HA, fatigue & arthromyalgia. All mild&self resolved. Disease flare in 1/180 pts (0.6%) 1st dose 4/118 (3.4%) 2nd dose https://t.co/5AB5CJfYt8
      RT @Janetbirdope: Do you use #septa in #renal #lupus if on high dose prednisone? @RheumNow #ACR21 8M212 lupus hub

      Janet Pope Janetbirdope

      3 years 2 months ago
      Do you use #septa in #renal #lupus if on high dose prednisone? @RheumNow #ACR21 8M212 lupus hub
      RT @Yuz6Yusof: After that fantastic Plenary III, we need a well-deserved timeout and time for stretching 🙆🏻‍♂ï

      Md Yuzaiful Md Yusof Yuz6Yusof

      3 years 2 months ago
      After that fantastic Plenary III, we need a well-deserved timeout and time for stretching 🙆🏻‍♂️ 🙆‍♀️! #wellness #ACR21 #RheumPix #RheumNow https://t.co/krF5tPAxsE
      RT @ericdeinmd: #ACR21 Knowledge Bowl - Enjoy the farmer's market!
      --> Cauliflower ears, cherries for gout, alfalfa a

      Eric Dein ericdeinmd

      3 years 2 months ago
      #ACR21 Knowledge Bowl - Enjoy the farmer's market! --> Cauliflower ears, cherries for gout, alfalfa and SLE... and of course anti-OJ myositis @Rheumnow https://t.co/K8aG1IKYCu
      RT @Janetbirdope: #SLE study hub re #Lupus nephritis rocks. #Rituximab ⬇️antiDNA but then rebound ⤴️. Thus desig

      Janet Pope Janetbirdope

      3 years 2 months ago
      #SLE study hub re #Lupus nephritis rocks. #Rituximab ⬇️antiDNA but then rebound ⤴️. Thus design of adding #belimumab to Rituximab=Less flares. Love the Hubs. #ACR21 @RheumNow https://t.co/MAhxJdmkWO 10.7326/M21-2078 #ACRBest https://t.co/qWPk5x1ZtM
      RT @synovialjoints: Younger age, male gender, geographic region, lower weight and BMI, dactylitis+ or enthesitis+, lower

      Dr. Antoni Chan synovialjoints

      3 years 2 months ago
      Younger age, male gender, geographic region, lower weight and BMI, dactylitis+ or enthesitis+, lower scores Pt-Pain, PtGA, TJC and HAQ-DI were baseline predictors for achieving MDA and DAPSA LDA at Week 56 in UPA treated patients @RheumNow #ACR21 Abst#1348 https://t.co/FSXarBoBM1 https://t.co/UMCjr6eCRm
      RT @ericdeinmd: #ACR21 Ab#1029 - Great poster by Dr. Guttmann, IRAD in Summit NJ:
      ▶️2019 EULAR/ACR SLE criteria vs t

      Eric Dein ericdeinmd

      3 years 2 months ago
      #ACR21 Ab#1029 - Great poster by Dr. Guttmann, IRAD in Summit NJ: ▶️2019 EULAR/ACR SLE criteria vs to 1997 ACR & SLICC ⭐️64% SLE pts: all 3 criteria. 10% only SLICC, 3% '97 ACR, 2% EULAR/ACR ⭐️Simliar gender, racial disparities to prior criteria @Rheumnow https://t.co/QzG78HJgw5 https://t.co/eyuYhj4Acf
      ×